Michael Austwick
Director at Verona Pharma plc (VRNA) since February 2024
Michael Austwick has filed 5 insider reports with the SEC since February 2024, as director at Verona Pharma plc (VRNA). Michael Austwick made no open-market purchases or sales in the last 12 months. The latest filing, on October 8, 2025, reports sale back to the company and exercise or conversion of a derivative at Verona Pharma plc (VRNA).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- $148K
Companies where Michael Austwick is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2024 | 0 | $148K | Oct 8, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 7, 2025VRNADirector Austwick Michael returned 84,712 units of Ordinary Shares to the company and converted options into 72,000 units of Ordinary Shares, closing all direct ownership in the companyForm 4Sale back to the companyExercise or conversion of a derivative
- Aug 1, 2025-$148KVRNADirector Austwick Michael converted options into 24,000 units of Ordinary Shares and sold $148,366 worth of Ordinary Shares (11,288 units at $13.14)Form 4Exercise or conversion of a derivativeOpen-market sale
- Apr 25, 2025VRNASEC Form 4 filed by Director Austwick MichaelForm 4Grant or award
- Feb 1, 2024VRNASEC Form 4 filed by Austwick MichaelForm 4Grant or award
- Feb 1, 2024VRNAMichael Austwick became an insiderForm 3New insider
Compare Michael Austwick with
- Michael Austwick vs Andrew Fisher1 shared
- Michael Austwick vs David Zaccardelli1 shared
- Michael Austwick vs Kathleen A. Rickard1 shared
- Michael Austwick vs Mark W Hahn1 shared
- Michael Austwick vs Anders Ullman1 shared
- Michael Austwick vs Mahendra Shah1 shared
Other insiders at the same companies
- Andrew FisherVRNA
- David ZaccardelliVRNA
- Kathleen A. RickardVRNA
- Mark W HahnVRNA
- Anders UllmanVRNA
- Mahendra ShahVRNA
- Vikas SinhaVRNA
- Lisa DeschampsVRNA
- David R EbsworthVRNA
- Martin EdwardsVRNA
- James Aloysius BradyVRNA
- Kenneth CunninghamVRNA
- Christina AckermannVRNA
Questions about Michael Austwick
- What is Michael Austwick's role at Verona Pharma plc?
- Michael Austwick reports to the SEC as director at Verona Pharma plc (VRNA), according to the latest filing on October 8, 2025.
- Has Michael Austwick bought or sold stock recently?
- The most recent open-market sale was on August 1, 2025: sold 11,288 shares of Verona Pharma plc (VRNA) for $148K at an average of $13.14.
- How do I get alerts when Michael Austwick files?
- Follow Michael Austwick on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Austwick (SEC CIK 0002009903). Totals count each trade once, skipping amendments whose original is on file, from Feb 2, 2024 on. View on SEC EDGAR · Get this as JSON